发明名称 |
METHODS FOR TREATING INFLAMMATORY AUTOIMMUNE DISORDERS |
摘要 |
The present invention features a method of treating or reducing the likelihood of an inflammatory autoimmune disorder (e.g., systemic lupus erythematosus (SLE)) or a kidney disorder (e.g., glomerulonephritis) in a subject by administering an inhibitor of calcium/calmodulin-dependent protein kinase type IV (CaMKIV). The invention additionally features methods of diagnosing a subject with SLE or a kidney disorder by determining the level or biological activity of a CaMKIV nucleic acid or polypeptide in a sample from a subject. Also included in the invention are methods for identifying compounds that inhibit CaMKIV for the treatment of an inflammatory autoimmune disorder (e.g., SLE) or a kidney disorder (e.g., glomerulonephritis). |
申请公布号 |
US2014161769(A1) |
申请公布日期 |
2014.06.12 |
申请号 |
US201313936792 |
申请日期 |
2013.07.08 |
申请人 |
Beth Israel Deaconess Medical Center, Inc. |
发明人 |
Tsokos George C.;Juang Yuang-Taung;Hahn Chun-Shin |
分类号 |
A61K31/18;A61K31/713;A61K45/06;C12N15/113 |
主分类号 |
A61K31/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating or reducing the likelihood of an inflammatory autoimmune disorder or a kidney disorder in a subject, said method comprising providing to said subject an inhibitor of calcium/calmodulin-dependent protein kinase type IV (CaMKIV), wherein said inhibitor is provided in an amount and for a duration that together are sufficient to treat or reduce the likelihood of said inflammatory autoimmune disorder or said kidney disorder in said subject.
|
地址 |
Boston MA US |